Chiome Bioscience Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was JPY 682.46 million compared to JPY 630.82 million a year ago. Net loss was JPY 1,220.02 million compared to JPY 1,242.87 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
123 JPY | -2.38% | -3.91% | -8.89% |
Apr. 01 | Chiome Bioscience Cancels License Agreements with ADC Therapeutics | MT |
Feb. 13 | Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited | CI |
1st Jan change | Capi. | |
---|---|---|
-8.89% | 44.54M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- 4583 Stock
- News Chiome Bioscience Inc.
- Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023